IP Library Granted Patent US 7,253,270
Granted Patent B2
US 7,253,270 · App. 10/198,938 · Granted Aug 7, 2007

Polynucleotide encoding a mutated HIV gp41 polypeptide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,253,270
App. No.
10/198,938
Granted
Aug 7, 2007
Kind
B2
Abstract

The invention provides a method of searching for and obtaining a vaccine against the pathogenic effects related to the infection of an animal or human host by a retrovirus that penetrates into a target cell of the host, and a vaccine obtained by the method are provided. The method includes preparing candidate vaccine agents based on a polypeptide comprising at least part of an envelope protein of a pathogenic strain of the retrovirus and selecting as the vaccine a modified polypeptide chosen from polypeptides that induces an immune response directed against an immunodominant region of an envelope protein of the retrovirus and not against a protein of the host.

Claims (1)

1. A polynucleotide encoding a polypeptide comprising a peptide sequence selected from the group consisting of SEQ ID NOs: 99 and 100.